This inventor holds 1 USPTO granted patent. Top assignee: Novartis Ag. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovative Mind of Nicolas Warin
Introduction
Nicolas Warin, an accomplished inventor based in Blotzheim, France, has made significant contributions to the field of pharmaceuticals through his innovative research and development work. His expertise lies in creating compounds that have the potential to revolutionize treatments for various diseases.
Latest Patents
Warin holds a patent for "Compounds and compositions for inhibiting the activity of HIF2-alpha and their methods of use." This invention involves compounds of formula (I) or a pharmaceutically acceptable salt form thereof. The patent details the specific substituents defined in the specification, including intermediates for the preparation of these compounds and pharmaceutical compositions comprising them. The application emphasizes the importance of these compounds in the treatment of diseases, showcasing his commitment to advancing medical science.
Career Highlights
Currently, Nicolas Warin is associated with Novartis AG, a leading global healthcare company known for its innovative pharmaceuticals. His role at Novartis allows him to work at the forefront of medical innovation, developing methodologies that target critical health issues. The experience he has gained throughout his career positions him as a key player in the field.
Collaborations
Throughout his professional journey, Warin has engaged in various collaborations that have strengthened his research endeavors. Partnering with other scientists and researchers within Novartis and beyond has enabled him to exchange ideas, enhance his work, and contribute to pioneering advances in pharmaceutical science.
Conclusion
Nicolas Warin stands out as an influential inventor with his groundbreaking work in developing compounds for medical applications. His patent reflects his dedication to addressing complex health challenges. As innovations advanced through his efforts continue to evolve, the impact of his contributions on the pharmaceutical industry and patient care is poised to be profound.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile